BEIJING, May 2, 2013 /PRNewswire-FirstCall/ -- China Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that the Company plans to ...

BEIJING, May 8, 2013 /PRNewswire-FirstCall/ -- China Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced its financial results for the ...

J&J, which makes everything from baby shampoo and Tylenol to biologic drugs and medical devices, has seen its revenue rebound after a rare decline in 2009, thanks to a surge of 11 new medicines launched since then.

Like its rivals, the company says it is focusing on conditions that lack adequate treatments, as well as expanding sales in emerging markets such as China and India. J&J's 11 experimental drugs, now in mid- or late-stage patient testing, include a ...

Huahai will commercialize four complex biological drugs developed by Oncobiologics for the Chinese market. The products will be manufactured in China at a Huahai facility there. The agreement also establishes a co-development and commercialization ...

Xellia's life-saving anti-infective products for multi-drug resistant infections address a growing global medical challenge, and the Company is a world leading supplier of Vancomycin and Colistimethate Sodium (CMS). Xellia's products are all ...

Additionally, iBio is developing select product candidates that have been derived from the iBioLaunch platform. The iBioLaunch platform is a proprietary, transformative technology for development and production of biologics using transient gene ...

The FDA cited the plant in 2011 for sampling and testing of materials and drug products, product record review and the company's process for inspecting the failure of some manufacturing batches to meet specifications. Those inspections led Impax to ...

Chinese biotech company Sino Biological Inc reached an agreement with Life Technologies Corp for protein product distribution and development worldwide. Shanghai Fosun Pharmaceutical (Group) Co has become the largest single shareholder of ...

Mr. Bisaro said the company would continue to pursue deals to bolster its generics business, specialty pharmaceuticals, as well as biosimilars, which are rough copies of biologic drugs derived from living cells. Actavis, of Parsippany, N.J., said it ...